Prognostic value of C-reactive protein/albumin ratio in predicting mortality in hemodialysis patients

Objective: Systemic inflammation and malnutrition are critical determinants of mortality in hemodialysis patients. The C-reactive protein/albumin ratio (CAR) integrates these two pathways. This study aimed to assess the prognostic value of CAR for all-cause mortality in maintenance hemodialysis patients and compare it with other inflammatory biomarkers. Methods: This multicenter retrospective study included 204 hemodialysis patients followed between January 2022 and January 2024. Patients were stratified into survivor ( n = 161) and non-survivor ( n = 43) groups. Demographic data and inflammatory biomarkers, including CAR, neutrophil/lymphocyte ratio (NLR), and systemic immune-inflammation index (SII), were analyzed. Multivariate logistic regression was used to identify independent predictors of mortality. Results: Non-survivors exhibited significantly higher median CAR levels (3.86 vs 1.72, p < 0.001) and lower Kt/V values compared to survivors. In ROC analysis, 6-month average Kt/V (AUC = 0.764) and RAR (AUC = 0.751) showed high discriminatory power, followed by CAR (AUC = 0.715). However, in multivariate regression, high CAR (>2.59) remained a robust independent predictor of mortality (odds ratio: 3.61, p = 0.002), alongside age and Kt/V, whereas RDW lost its significance. Conclusions: CAR may serve as a simple, cost-effective, and independent prognostic marker for all-cause mortality in hemodialysis patients. While dialysis adequacy (Kt/V) remains the dominant predictor, integrating CAR into routine monitoring has the potential to enhance risk stratification by capturing the malnutrition-inflammation burden, pending validation in future prospective cohorts.

Authors

Institutions

Publication Details

Journal
The International Journal of Artificial Organs
Published
2026-11-19
DOI
https://doi.org/10.1177/03913988261446077
Primary Topic
Dialysis and Renal Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic value of C-reactive protein/albumin ratio in predicting mortality in hemodialysis patients

Muammer Avci, Atila Altuntaş, Ümit Aydın, Elif Yilmaz Aydin
The International Journal of Artificial Organs
Dialysis and Renal Disease Management
article

Prognostic value of C-reactive protein/albumin ratio in predicting mortality in hemodialysis patients

Muammer Avci, Atila Altuntaş, Ümit Aydın, Elif Yilmaz Aydin
article en

Abstract

Objective: Systemic inflammation and malnutrition are critical determinants of mortality in hemodialysis patients. The C-reactive protein/albumin ratio (CAR) integrates these two pathways. This study aimed to assess the prognostic value of CAR for all-cause mortality in maintenance hemodialysis patients and compare it with other inflammatory biomarkers. Methods: This multicenter retrospective study included 204 hemodialysis patients followed between January 2022 and January 2024. Patients were stratified into survivor ( n = 161) and non-survivor ( n = 43) groups. Demographic data and inflammatory biomarkers, including CAR, neutrophil/lymphocyte ratio (NLR), and systemic immune-inflammation index (SII), were analyzed. Multivariate logistic regression was used to identify independent predictors of mortality. Results: Non-survivors exhibited significantly higher median CAR levels (3.86 vs 1.72, p < 0.001) and lower Kt/V values compared to survivors. In ROC analysis, 6-month average Kt/V (AUC = 0.764) and RAR (AUC = 0.751) showed high discriminatory power, followed by CAR (AUC = 0.715). However, in multivariate regression, high CAR (>2.59) remained a robust independent predictor of mortality (odds ratio: 3.61, p = 0.002), alongside age and Kt/V, whereas RDW lost its significance. Conclusions: CAR may serve as a simple, cost-effective, and independent prognostic marker for all-cause mortality in hemodialysis patients. While dialysis adequacy (Kt/V) remains the dominant predictor, integrating CAR into routine monitoring has the potential to enhance risk stratification by capturing the malnutrition-inflammation burden, pending validation in future prospective cohorts.

The International Journal of Artificial Organs
Süleyman Demirel Üniversitesi (TR), Isparta University of Applied Sciences (TR)
Dialysis and Renal Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon